Professor of Medicine
Attending, Transplant Infectious Diseases Service
University of Chicago
Dr. Kathleen (Kate) Mullane is a board certified Infectious Diseases physician. She has been at University of Chicago since 2005 achieving the rank of Professor and acting as the Director of Infectious Disease Clinical trials as well as being an attending in the Trandplant Infectious Diseases program. Her investigations have included the assessment of the risk factors associated with the development of infections in immunocompromised hosts and prevention and treatment of these infections. She has conducted studies of the epidemiology and treatment of Clostridium difficile infection (CDI) and COVID-19. She has participated in over 100 clinical trials sponsored by the CDC, NIH/NIAID, and PHARMA involving the epidemiology, prevention and treatment of infections in those who are immunocompromised through Stem Cell Transplantation, Solid Organ Transplantation and by the Human Immunodeficiency Virus. She has been involved in antifungal trials from the inception of lipid formulations of Amphotericin B in the early 1980’s to the current azole, echinocandin and triterpenoid agents. She has been involved in CMV trials from studies evaluating the pharmacokinetics of gancyclovir in the early 2000’s through the latest investigational agents including letermovir, maribavir and cytotoxic T-cells. Dr. Mullane was involved in the CDC-VA tuberculosis consortium trials and has been involved in antibiotic trials for agents being evaluated for the treatment of antimicrobial resistant organisms. Dr. Mullane has as well, participated in vaccine trials for varicella, influenza, CDI and most recently COVID-19. Her work has led to authorship on nearly 100 peer reviewed publications and several book chapters.
Kate began her Infectious Diseases career at The University of Illinois – West Side VA Medical Center in Chicago where she served as an Associate Professor and Director of Infection Control as well as an attending physician on the Infectious Diseases services. There she conducted translational research evaluating neutrophil function, oxidative capacity / burst and associated accelerated neutrophil apoptosis in HIV infected individuals until 1999. From 1999 to 2005, Dr. Mullane was Associate Professor of Medicine and the Director of Clinical Trials for Loyola University Stritch School of Medicine as well being the Director of the Ryan White Grant Program at Loyola and served as an attending physician in Infectious Diseases.
Dr. Mullane is a Fellow of the Infectious Diseases Society of America (IDSA), a Fellow of the American Society of Transplantation (AST) and a member of the American Society for Transplantation and Cellular Therapy (ASTCT). She has served on the Research Committee and Guidelines committee for IDSA; she participates in the AST Infectious Diseases Community of Practice (COP), and the ASTCT she serves on the steering committee for the Special Interest Group (SIG) for Infectious Diseases. Dr Mullane has participated in Scientific Advisory Committees, Data Safety Monitoring Committees and Adjudication Committees for major clinical trials sponsored by PHARMA industries. She has participated in multiple committees at the University of Chicago including: Pharmacy and Therapeutic, Antimicrobial Subcommittee, Institutional Review Board and the Clinical Trials Committee. She has been selected as a Regional Top Doctor by Castle Connelly / US News and World Report and Chicago Magazine annually since 2012. She is most proud of receiving the Clinician of the Year at University of Chicago in 2019 and the Most Inspirational Physician award while serving at Loyola University.
Dr Mullane received her Bachelors of Science Degree in Pharmacy Practice from the University of Iowa in 1980 and her Doctor of Pharmacy from University of the Sciences in Philadelphia in 1982. She completed a Clinical Pharmacy Residency at the University of Illinois Medical Center at Chicago in 1983 after which time she remained as a faculty member of the University of Illinois at Chicago Pharmacy Practice department until she changed her path and underwent her medical school education and received her Doctor or Osteopathic Medicine from Midwestern University (the Chicago College of Osteopathic Medicine) in 1989. She served and completed her Internal Medicine residency at Rush University Medical Center in Chicago in 1992 and in 1994 completed her Infectious Diseases fellowship at the University of Illinois – University of Chicago, Combined Infectious Diseases fellowship program.
Dr. Mullane is grounded by her spouse, Dr. Michael R. Mullane (a mixed marriage as he is an Oncologist) and their son, Russell, and 2 standard schnausers (Gandalf and Eowyn).
Disclosure: Ansun (Individual(s) Involved: Self): Scientific Research Study Investigator; Astellas (Individual(s) Involved: Self): Scientific Research Study Investigator; Gilead (Individual(s) Involved: Self): Scientific Research Study Investigator; GSK (Individual(s) Involved: Self): Advisor or Review Panel member; Merck (Individual(s) Involved: Self): Advisor or Review Panel member, Scientific Research Study Investigator; Novartis (Individual(s) Involved: Self): Scientific Research Study Investigator; Roche-Genentech (Individual(s) Involved: Self): Scientific Research Study Investigator; Vendanta (Individual(s) Involved: Self): Scientific Research Study Investigator
Saturday, October 24, 2020
10:00am – 11:15am EDT